Zydus Cadila gets USFDA nod for anti-bacterial drug

Drug firm Zydus Cadila said it had received approval from the U.S. Food & Drug Administration to market Azithromycin for Oral Suspension USP, used to treat bacterial infections, in the American market. The medication is used to treat respiratory infections, skin infections, ear infections and sexually transmitted diseases. The drug will be manufactured at the group’s formulations manufacturing facility at Baddi.

Source : https://www.thehindu.com/todays-paper/tp-business/zydus-cadila-gets-usfda-nod-for-anti-bacterial-drug/article24576849.ece

About ChinmayaIAS Academy - Current Affairs

Check Also

Stimulating white blood cells helps clear TB bacteria

Potency of TB drugs improved many times when two receptors of the immune cells were …

Leave a Reply

Your email address will not be published. Required fields are marked *